Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 7/20 | 0.63 |
| ▸ | ADRB1 | P08588 | 7/20 | 0.63 |
| ▸ | ADRB3 | P13945 | 7/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MLNR | O43193 | 1/20 | 0.45 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17629569 | 1.00 | ADRB2 (0.63) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL446204 | 1.00 | ADRB2 (0.63) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL29613210 | 1.00 | ADRB2 (0.63) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL12083435 | 0.91 | ADRB2 (0.68) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL120454 | 0.90 | ALDH1A1 (0.61) | ADRB2ADRB1ADRB3ALDH1A1NPC1 | |
| SCHEMBL1031052 | 0.86 | ADRB2 (0.53) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL24292233 | 0.85 | ADRB2 (0.66) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL16088412 | 0.85 | ADRB2 (0.66) | ADRB2ADRB1ADRB3TDP1LMNA | |
| Glycerin SCHEMBL22574599 | 0.84 | TDP1 (0.63) | ADRB2ADRB1ADRB3TDP1LMNA | |
| Ethyl Salicylate SCHEMBL27636321 | 0.84 | TSHR (0.61) | ADRB2ADRB1ADRB3TDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3197460-B1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2022-04-20 | — | — | EP | claimed |
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2017-10-05 | — | — | US | claimed |
| EP-3197460-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | Greenpharma (FR) | 2017-08-02 | — | — | EP | claimed |
| WO-2016046456-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA (FR) | 2016-03-31 | — | — | WO | claimed |
| EP-3197460-B1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2022-04-20 | — | — | EP | disclosed |
| EP-3197460-B1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2022-04-20 | — | — | EP | disclosed |
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2017-10-05 | — | — | US | disclosed |
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2017-10-05 | — | — | US | disclosed |
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2017-10-05 | — | — | US | disclosed |
| EP-3197460-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | Greenpharma (FR) | 2017-08-02 | — | — | EP | disclosed |
| WO-2016046456-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA (FR) | 2016-03-31 | — | — | WO | disclosed |
| WO-2016046456-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA (FR) | 2016-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | CCL2, CCL11, CCL5 | ADRB2 2720/4885ADRB1 2665/4885ADRB3 2814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.